亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

萊陽宇辰化工研究所  

噻托溴銨,東莨菪醇等醫藥原料及中間體

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:康曉蓮
  • 電話:150-63393085
  • 郵件:yuchen_kang@hotmail.com
  • QQ:1402659873
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 3-哌啶甲酸 3-羧酸哌啶 498-95-3
3-哌啶甲酸 3-羧酸哌啶 498-95-3
單價 面議對比
詢價 暫無
發貨 山東煙臺市付款后3天內
過期 長期有效
更新 2010-12-06 14:45
 
詳細信息
2-哌啶甲酸 2-羧酸哌啶 535-75-1 Piperidine-2-carboxylic acid白色晶體粉末>=98
3-哌啶甲酸 3-羧酸哌啶498-95-3 Piperidine-3-carboxylic acid淺黃色結晶粉末>=97
4-哌啶甲酸 4-羧酸哌啶498-94-2 Piperidine-4-carboxylic acid白色晶體粉末>=99
N-Boc-2-哌啶甲酸 N-Boc-Piperidine-2-carboxylic acid 98303-20-9白色-類白色晶體粉末>=98
N-Boc-3-哌啶甲酸 84358-12-3 N-Boc-Piperidine-3-carboxylic acid白色-類白色晶體粉末>=98
N-Boc-4-哌啶甲酸 84358-13-4 N-Boc-Piperidine-4-carboxylic acid白色-類白色晶體粉末>=98
©2025 萊陽宇辰化工研究所 版權所有   技術支持:化工網   訪問量:12725  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |